215 related articles for article (PubMed ID: 15358021)
21. Prognostic Impact of B-Type Natriuretic Peptide on Long-Term Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Myocardial Infarction Without Creatine Kinase Elevation.
Takahashi N; Ogita M; Suwa S; Nakao K; Ozaki Y; Kimura K; Ako J; Noguchi T; Yasuda S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
Int Heart J; 2020 Sep; 61(5):888-895. PubMed ID: 32921675
[TBL] [Abstract][Full Text] [Related]
22. Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction.
Warren J; Mehran R; Yu J; Xu K; Bertrand ME; Cox DA; Lincoff AM; Manoukian SV; Ohman EM; Pocock SJ; White HD; Stone GW
Am J Cardiol; 2015 Feb; 115(4):428-33. PubMed ID: 25542393
[TBL] [Abstract][Full Text] [Related]
23. The role of leukocyte counts in patients with unstable angina pectoris or myocardial infarction; prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levels.
Akhtar N; Adil MM; Ahmed W; Habib-ur-Rehman ; Shahs MA
J Pak Med Assoc; 2011 Jan; 61(1):51-4. PubMed ID: 22368903
[TBL] [Abstract][Full Text] [Related]
24. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Sadanandan S; Cannon CP; Gibson CM; Murphy SA; DiBattiste PM; Braunwald E;
J Am Coll Cardiol; 2004 Aug; 44(4):799-803. PubMed ID: 15312862
[TBL] [Abstract][Full Text] [Related]
25. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
Gyöngyösi M; Glogar D; Weidinger F; Domanovits H; Laggner A; Wojta J; Zorn G; Iordanova N; Huber K
Am Heart J; 2004 Jan; 147(1):158-64. PubMed ID: 14691435
[TBL] [Abstract][Full Text] [Related]
26. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
[TBL] [Abstract][Full Text] [Related]
27. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
28. The effect of streptokinase therapy in STEMI and conventional therapy in NSTEMI patients on TIMI risk index, B-type natriuretic peptide and high-sensitive C-reactive protein.
Kurt IH; Batur MK; Unal I
Anadolu Kardiyol Derg; 2011 Sep; 11(6):530-5. PubMed ID: 21821500
[TBL] [Abstract][Full Text] [Related]
29. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
[TBL] [Abstract][Full Text] [Related]
31. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
32. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction.
Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z
Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472
[TBL] [Abstract][Full Text] [Related]
33. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction.
Matsui S; Ishii J; Kitagawa F; Kuno A; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Tanaka I; Nomura M; Hishida H; Ozaki Y
Atherosclerosis; 2010 May; 210(1):220-5. PubMed ID: 19945702
[TBL] [Abstract][Full Text] [Related]
34. Relationship between B-type natriuretic peptide and short-term prognosis in non-diabetic patients with ST-segment elevation myocardial infarction.
Wei P; Fu Q; Tao ZQ; Han B; Zhang YG; Huang YJ; Ling L; Yang XJ
Eur Rev Med Pharmacol Sci; 2016; 20(4):721-5. PubMed ID: 26957276
[TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial.
Morrow DA; Scirica BM; Sabatine MS; de Lemos JA; Murphy SA; Jarolim P; Theroux P; Bode C; Braunwald E
J Am Coll Cardiol; 2010 Mar; 55(12):1189-1196. PubMed ID: 20298924
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic value of B-type natriuretic peptide in unstable angina and non-ST-elevation myocardial infarction].
Molina-Mora MJ; Cabrera-Bueno F; Jiménez-Navarro M; Linde-Estrella A; García-Pinilla JM; Teresa-Galván Ed
Med Clin (Barc); 2009 Oct; 133(15):569-73. PubMed ID: 19783260
[TBL] [Abstract][Full Text] [Related]
37. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.
Sahinarslan A; Cengel A; Okyay K; Yazici HU; Elbey S; Cemri M; Ozdemir M; Timurkaynak T
Coron Artery Dis; 2005 Jun; 16(4):225-9. PubMed ID: 15915074
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of B-type natriuretic peptide levels on admission in patients with acute ST elevation myocardial infarction.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Rudzki D; Główczyńska R; Rudowski R; Opolski G
Acta Cardiol; 2005 Oct; 60(5):537-42. PubMed ID: 16261786
[TBL] [Abstract][Full Text] [Related]
39. Detection by near-infrared spectroscopy of large lipid cores at culprit sites in patients with non-ST-segment elevation myocardial infarction and unstable angina.
Madder RD; Husaini M; Davis AT; VanOosterhout S; Harnek J; Götberg M; Erlinge D
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1014-21. PubMed ID: 25418711
[TBL] [Abstract][Full Text] [Related]
40. The determinants of B-type natriuretic peptide release in acute, non-ST-segment elevation myocardial infarction.
Vorlat A; Claeys MJ; Snoep L; Haine S; Miljoen H; Bosmans J; Vrints CJ
Acta Cardiol; 2011 Jun; 66(3):281-5. PubMed ID: 21744696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
